EUVIMEDEUVIMED entdecken
Klinische Studie

Confirmatory Testing for Primary Aldosteronism

Alexander A Leung iD, Raj S Padwal iD, Gregory L Hundemer iD, Erik Venos iD, David J T Campbell, Daniel T Holmes iD, Dennis J Orton iD, C Benny So iD, Stefan J Przybojewski iD, Cori E Caughlin, Janice L Pasieka iD, Doreen M Rabi und 1 weitere

Annals of Internal Medicine · 2025-07 · 178 (7) · 948-956

DOI: 10.7326/annals-24-03153 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Annals of Internal Medicine, 2025-07. Verfasst von Alexander A Leung und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine, and Department of Community Health Sciences, University of Calgary, Calgary, Albert…. Hauptthemen laut MEDLINE: Hyperaldosteronism, Aldosterone. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Confirmatory testing to verify the diagnosis of primary aldosteronism (PA) in patients who have an abnormal screening result is of uncertain benefit. OBJECTIVE: To perform a blinded assessment of the seated saline suppression test (SSST). DESIGN: Diagnostic test accuracy study. (ClinicalTrials.gov: NCT04422756). SETTING: The regional Endocrine Hypertension Clinic in Calgary, Alberta, Canada. PARTICIPANTS: 156 adults with a positive screening result for PA. INTERVENTION: The SSST was done by administering 2 L of 0.9% sodium chloride intravenously over 4 hours with the patient seated. MEASUREMENTS: Treatment response was considered the reference standard for determining disease status and was based on blood pressure lowering, reduction of antihypertensive drug dose, and normalization of biochemistry. Measures of diagnostic test accuracy, including sensitivity, specificity, positive predictive value, and negative predictive value, were estimated. RESULTS: Post-SSST aldosterone concentrations measured using immunoassay overlapped between treatment responders (median, 329 pmol/L [IQR, 227 to 525 pmol/L]) and nonresponders (median, 255 pmol/L [IQR, 162 to 346 pmol/L]). The SSST could not discriminate between response statuses (area under the curve, 62.1% [95% CI, 45.1% to 79.1%]). The positive and negative likelihood ratios were equivocal for aldosterone cutoffs ranging from 140 to 300 pmol/L. These findings remained consistent after differences in treatment, occurrence of hypokalemia, and laboratory assay used were accounted for. LIMITATION: The study population had many patients with high-risk features of PA and few nonresponders. CONCLUSION: The SSST is associated with a high false-negative rate, and reliance on it may lead to missed opportunities for intervention. PRIMARY FUNDING SOURCE: The Canadian Institutes of Health Research, Hypertension Canada, and the Heart and Stroke Foundation of Canada.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismAldosteroneHumansMiddle AgedFemaleMaleAdultSensitivity and SpecificitySodium ChloridePredictive Value of TestsAgedAntihypertensive AgentsHypertension

Substanzen

AldosteroneSodium ChlorideAntihypertensive Agents

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Medicine, and Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada (A.A.L., D.J.T.C., D.M.R.).
  • Division of General Internal Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada (R.S.P.).
  • Division of Nephrology, Department of Medicine, and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada (G.L.H.).
  • Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, Alberta, Canada (E.V., G.A.K.).
  • St. Paul's Hospital and Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (D.T.H.).
  • Alberta Precision Laboratories and Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada (D.J.O.).

ORCID-Profile: Alexander A Leung, Raj S Padwal, Gregory L Hundemer, Erik Venos, Daniel T Holmes, Dennis J Orton, C Benny So, Stefan J Przybojewski, Janice L Pasieka, Gregory A Kline

Zitieren

APA

Leung, A. A., Padwal, R. S., Hundemer, G. L., Venos, E., Campbell, D. J. T., Holmes, D. T., Orton, D. J., So, C. B., Przybojewski, S. J., Caughlin, C. E., Pasieka, J. L., Rabi, D. M., & Kline, G. A. (2025). Confirmatory Testing for Primary Aldosteronism. Annals of Internal Medicine, 178(7), 948-956. https://doi.org/10.7326/annals-24-03153

Vancouver

Leung AA, Padwal RS, Hundemer GL, Venos E, Campbell DJT, Holmes DT, et al. Confirmatory Testing for Primary Aldosteronism. Annals of Internal Medicine. 2025;178(7):948-956. doi:10.7326/annals-24-03153

BibTeX
@article{Leung2025,
  author = {Leung, Alexander A and Padwal, Raj S and Hundemer, Gregory L and Venos, Erik and Campbell, David J T and Holmes, Daniel T and Orton, Dennis J and So, C Benny and Przybojewski, Stefan J and Caughlin, Cori E and Pasieka, Janice L and Rabi, Doreen M and Kline, Gregory A},
  title = {Confirmatory Testing for Primary Aldosteronism},
  journal = {Annals of Internal Medicine},
  year = {2025},
  volume = {178},
  number = {7},
  pages = {948--956},
  doi = {10.7326/annals-24-03153}
}
Kostenlos starten →